---
title: "SOLARTECH INT'L has completed the sale of 100% equity in Dongguan Huayi Copper Industry"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/230985321.md"
description: "According to the announcement from SOLARTECH INT'L, all preconditions under the equity transfer agreement for the sale of 100% equity in Dongguan Huayi Copper Industry Co., Ltd. have been met, and the sale was completed on March 6, 2025. After the completion of the sale, the target company is no longer a subsidiary of the company"
datetime: "2025-03-07T11:52:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230985321.md)
  - [en](https://longbridge.com/en/news/230985321.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230985321.md)
generator: "portal-rs"
---

# SOLARTECH INT'L has completed the sale of 100% equity in Dongguan Huayi Copper Industry

According to the announcement from StarTech Holdings (01166), the sale of 100% equity in Dongguan Huayi Copper Industry Co., Ltd. has been completed, with all conditions precedent under the equity transfer agreement having been met. Following the completion of the sale on March 6, 2025, the target company is no longer a subsidiary of the company

### Related Stocks

- [02940.HK](https://longbridge.com/en/quote/02940.HK.md)
- [01166.HK](https://longbridge.com/en/quote/01166.HK.md)

## Related News & Research

- [Solartech International Publishes ESG Report](https://longbridge.com/en/news/302527332.md)
- [Solartech Seeks Shareholder Approval to Buy Back Up to 10% of Shares](https://longbridge.com/en/news/302527112.md)
- [The bank of Nvidia is getting more ‘disciplined,’ selective](https://longbridge.com/en/news/306148745.md)
- [PRESS DIGEST-New York Times business news - November 20](https://longbridge.com/en/news/306242079.md)
- [NetEase Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into NetEase (NTES)](https://longbridge.com/en/news/306200520.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**